Last reviewed · How we verify

Administration of Ropivacaïne — Competitive Intelligence Brief

Administration of Ropivacaïne (Administration of Ropivacaïne) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia / Pain Management.

phase 3 Local anesthetic (amide) Voltage-gated sodium channels Anesthesia / Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Administration of Ropivacaïne (Administration of Ropivacaïne) — Centre Hospitalier Departemental Vendee. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Administration of Ropivacaïne TARGET Administration of Ropivacaïne Centre Hospitalier Departemental Vendee phase 3 Local anesthetic (amide) Voltage-gated sodium channels
LIDOCAINE 1 % LIDOCAINE 1 % Ain Shams Maternity Hospital marketed Local anesthetic Voltage-gated sodium channels
Lidocaine and sodium bicarbonate Lidocaine and sodium bicarbonate University of Zurich marketed Local anesthetic Voltage-gated sodium channels
Lidoderm 5% patch Lidoderm 5% patch Nicole K Brogden marketed Local anesthetic Voltage-gated sodium channels
Mepivacaine Injection Mepivacaine Injection Nova Scotia Health Authority marketed Local anesthetic (amide) Voltage-gated sodium channels
lignocaine+bicarbonate lignocaine+bicarbonate Aligarh Muslim University marketed Local anesthetic Voltage-gated sodium channels
intravenous lidocaine (IVL) intravenous lidocaine (IVL) Ciusss de L'Est de l'Île de Montréal marketed Local anesthetic; Class IB antiarrhythmic Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

  1. Poznan University of Medical Sciences · 4 drugs in this class
  2. Nantes University Hospital · 3 drugs in this class
  3. Bozyaka Training and Research Hospital · 2 drugs in this class
  4. ASST Gaetano Pini-CTO · 2 drugs in this class
  5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
  6. Chiang Mai University · 1 drug in this class
  7. Beijing Tiantan Hospital · 1 drug in this class
  8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
  9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
  10. China Medical University, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Administration of Ropivacaïne — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-ropivaca-ne. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: